Benjamin Jackson

Stock Analyst at Jefferies

(n/a)

# 4,933

Out of 5,182 analysts

2

Total ratings

n/a

Success rate

-10.3%

Average return

Main Sectors:

Top Industries:

Biotechnology Drug Manufacturers - Specialty & Generic

Stocks Rated by Benjamin Jackson

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	GMAB Genmab	Reinstates: Buy	$42	$26.79	+54.91%	1	Feb 17, 2026
	EVO Evotec SE	Downgrades: Hold	$8.7 → $3.8	$2.98	+27.52%	1	Oct 7, 2024

Genmab

Feb 17, 2026

Reinstates: Buy

Price Target: $42

Current: $26.79

Upside: +54.91%

Evotec SE

Oct 7, 2024

Downgrades: Hold

Price Target: $8.7 → $3.8

Current: $2.98

Upside: +27.52%